Holen Sie sich die Stockscreener-App
2.78
0.71%
-0.02
Handel nachbörslich:
2.77
-0.010
-0.36%
OncoCyte Corporation Aktie (OCX) Neueste Nachrichten
Oncocyte Raises $29.1 Million to Develop, Commercialize Transplant Assays - Orange County Business Journal
OncoCyte Corporation (OCX): Among Cheapest Stocks Insiders Are Buying Recently - Insider Monkey
Oncocyte secures $29.1 million to advance FDA assay - MSN
Broadwood Partners acquires OncoCyte shares worth $9.24 million - MSN
OncoCyte stock hits 52-week low at $1.92 amid market challenges - MSN
Oncocyte corp's Patrick Smith acquires shares worth $2.2 million - MSN
Oncocyte corp CFO buys $200,000 in stock By Investing.com - Investing.com Australia
Oncocyte corp CFO buys $200,000 in stock - MSN
Oncocyte Corp CFO Acquires 97,561 Shares in Private Placement - TradingView
Oncocyte corp's Patrick Smith acquires shares worth $2.2 million By Investing.com - Investing.com South Africa
Oncocyte corp’s Patrick Smith acquires shares worth $2.2 million By Investing.com - Investing.com UK
Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - The Manila Times
Exclusive: Oncocyte (OCX) CEO & CFO to Meet Top Investors at BTIG's Elite Healthcare Conference - StockTitan
Oncocyte Corp enters into securities purchase agreements - Medical Buyer
Broadwood Partners acquires OncoCyte shares worth $9.24 million By Investing.com - Investing.com Nigeria
Oncocyte Prices $29 Million Stock Offerings -February 10, 2025 at 12:41 pm EST - Marketscreener.com
Oncocyte prices $29.1M equity offering - MSN
Oncocyte Secures $29.1Mln Funding Led By Bio-Rad To Advance Transplant Diagnostics, Stock Down - Nasdaq
OncoCyte’s $29.1M Funding Through Securities Agreements - TipRanks
Oncocyte Prices $29.1 Million Equity Offering - The Manila Times
ForexTV | Small Business Resources - ForexTV.com
Oncocyte (OCX) Secures Game-Changing $29.1M Investment to Revolutionize Early Transplant Rejection Detection - StockTitan
Oncocyte corp investor Patrick Smith buys $1,839 in shares By Investing.com - Investing.com South Africa
Oncocyte corp investor Patrick Smith buys $1,839 in shares - MSN
Oncocyte Corporation (NASDAQ:OCX) Shares Rebounded 7.25% From Their Lows – But Can They Continue? - Marketing Sentinel
Oncocyte corp shareholder Patrick W Smith acquires $34,114 in stock - Investing.com India
Oncocyte corp shareholder Patrick W Smith acquires $34,114 in stock By Investing.com - Investing.com Australia
OncoCyte (STU:7OC0) PS Ratio : 47.04 (As of Jan. 15, 2025) - GuruFocus.com
OncoCyte Co. (NASDAQ:OCX) Shares Bought by Geode Capital Management LLC - Defense World
StockNews.com Initiates Coverage on OncoCyte (NASDAQ:OCX) - Defense World
OncoCyte Corporation (NASDAQ: OCX) Enters Amendment to Lease Agreement with Induce Biologics USA, Inc. and Cushing Ventures, LLCOn January 2, 2025, Oncocyte Corporation announced in a Form 8-K filing that it has entered into an Amendment to a - Defense World
Oncocyte Corp amends lease agreement, sets expiration date By Investing.com - Investing.com Nigeria
Oncocyte Corp amends lease agreement, sets expiration date - Investing.com
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer - Markets Insider
Oncocyte names Dr. Paul Billings as Consulting CMO - Investing.com India
3.13%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):